These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 27705895)

  • 21. Impact of post-dilatation on strut apposition of second-generation bioresorbable vascular scaffolds: Key role for scaffold thrombosis and prognosis?
    Frangieh AH; Jaguszewski M; Imori Y; Obeid S; Templin C
    Cardiol J; 2018; 25(1):148-150. PubMed ID: 29512102
    [No Abstract]   [Full Text] [Related]  

  • 22. Use of a bioresorbable novolimus eluting vascular scaffold fails a hybrid PCI strategy with drug eluting stent.
    Schneider VS; Skurk C; Riedel M; Abdelwahed YS; Landmesser U; Leistner DM
    Clin Res Cardiol; 2017 Jul; 106(7):557-559. PubMed ID: 28374059
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment of in-stent restenosis with bioresorbable vascular scaffolds: optical coherence tomography insights.
    Rivero F; Bastante T; Cuesta J; Benedicto A; Restrepo JA; Alfonso F
    Can J Cardiol; 2015 Mar; 31(3):255-9. PubMed ID: 25660152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intraluminal bioresorbable vascular scaffold dismantling with aneurysm formation leading to very late thrombosis.
    Patel A; Nazif T; Stone GW; Ali ZA
    Catheter Cardiovasc Interv; 2017 Apr; 89(5):876-879. PubMed ID: 28145045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
    Onuma Y; Serruys PW; Muramatsu T; Nakatani S; van Geuns RJ; de Bruyne B; Dudek D; Christiansen E; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Garcia-Garcia HM; Veldhof S; Rapoza R; Ormiston JA
    JACC Cardiovasc Interv; 2014 Dec; 7(12):1400-11. PubMed ID: 25523532
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Edge vascular response after percutaneous coronary intervention: an intracoronary ultrasound and optical coherence tomography appraisal: from radioactive platforms to first- and second-generation drug-eluting stents and bioresorbable scaffolds.
    Gogas BD; Garcia-Garcia HM; Onuma Y; Muramatsu T; Farooq V; Bourantas CV; Serruys PW
    JACC Cardiovasc Interv; 2013 Mar; 6(3):211-21. PubMed ID: 23517830
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Left main "Culotte in Culotte" to manage a trapped broken balloon.
    Ancona MB; Giannini F; Jabbour RJ; Tanaka A; Regazzoli D; Mangieri A; Carlino M; Colombo A
    Int J Cardiol; 2016 Oct; 221():347-9. PubMed ID: 27404703
    [No Abstract]   [Full Text] [Related]  

  • 28. Late Malapposition After Bare-Metal Stent, But Not Bioresorbable Scaffold: Insights on Intraindividual Heterogeneity in Plaque and Device Response.
    Cortese B; Buccheri D; Silva Orrego P; Biondi-Zoccai G
    J Invasive Cardiol; 2015 Aug; 27(8):E171-2. PubMed ID: 26232021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A 12-month angiographic and optical coherence tomography follow-up after bioresorbable vascular scaffold implantation in patients with ST-segment elevation myocardial infarction.
    Kochman J; Tomaniak M; Kołtowski Ł; Jąkała J; Proniewska K; Legutko J; Roleder T; Pietrasik A; Rdzanek A; Kochman W; Brugaletta S; Kaluza GL
    Catheter Cardiovasc Interv; 2015 Oct; 86(4):E180-9. PubMed ID: 26015294
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is bioresorbable vascular scaffold acute recoil affected by baseline renal function and scaffold selection?
    Gunes HM; Yılmaz FK; Gokdeniz T; Demir GG; Guler E; Guler GB; Karaca O; Cakal B; İbişoğlu E; Boztosun B
    Int J Cardiol; 2016 Dec; 224():388-393. PubMed ID: 27681252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Longitudinal Stent Deformation: Precise Diagnosis With Optical Coherence Tomography.
    Hernández-Matamoros H; Gonzálvez-Garcia A; Moreno-Gómez R; Jiménez-Valero S
    J Invasive Cardiol; 2019 Dec; 31(12):E395. PubMed ID: 31786534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early Multiple Coronary Micro Aneurysms After Bioresorbable Vascular Scaffold Implantation.
    Picard F; L'allier PL; Tanguay JF
    Can J Cardiol; 2017 Feb; 33(2):292.e9-292.e11. PubMed ID: 27876562
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stents Coated With Mammalian Target of Rapamycin Inhibitors (mTOR) Appear to Be the Best Choice in Patients With Antiphospholipid Syndrome and Myocardial Infarction.
    Mora-Ramírez M; González-Pacheco H; Amezcua-Guerra LM
    J Clin Rheumatol; 2016 Aug; 22(5):281. PubMed ID: 27464778
    [No Abstract]   [Full Text] [Related]  

  • 34. Neoatherosclerosis as the cause of late failure of a bioresorbable vascular scaffold.
    Mangiameli A; Ohno Y; Attizzani GF; Capodanno D; Tamburino C
    JACC Cardiovasc Interv; 2015 Apr; 8(4):633-4. PubMed ID: 25819179
    [No Abstract]   [Full Text] [Related]  

  • 35. Managing bioabsorbable vascular scaffold failure: combined scaffold restenosis and late-acquired coronary aneurysm treated with self-expandable stent.
    La Manna A; Mangiameli A; Capodanno D; Longo G; Sgroi C; Tamburino C
    Can J Cardiol; 2015 May; 31(5):691.e1-3. PubMed ID: 25936494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bioresorbable vascular scaffold fracture in the overlapping zone as cause of accelerated neoatherosclerosis and in-scaffold very-late thrombosis.
    Mangiameli A; Fajadet J; Dumonteil N
    Int J Cardiovasc Imaging; 2017 Jan; 33(1):1-3. PubMed ID: 27562758
    [No Abstract]   [Full Text] [Related]  

  • 37. Bioresorbable everolimus-eluting vascular scaffold in patients with ST-segment elevation myocardial infarction: Optical coherence tomography evaluation and clinical outcomes.
    Kochman J; Tomaniak M; Pietrasik A; Kołtowski Ł; Rdzanek A; Huczek Z; Mazurek T; Jąkała J; Ząbek A; Legutko J; Kochman W; Filipiak KJ
    Cardiol J; 2015; 22(3):315-22. PubMed ID: 25428734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coronary CT Angiography for In-Stent Restenosis: Diagnosis and Therapeutic Planning.
    Rozado J; Pascual I; Martín M; Calvo J; Avanzas P; Morís C
    J Invasive Cardiol; 2017 Jun; 29(6):E71. PubMed ID: 28570241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A next-generation bioresorbable coronary scaffold system: from bench to first clinical evaluation: 6- and 12-month clinical and multimodality imaging results.
    Verheye S; Ormiston JA; Stewart J; Webster M; Sanidas E; Costa R; Costa JR; Chamie D; Abizaid AS; Pinto I; Morrison L; Toyloy S; Bhat V; Yan J; Abizaid A
    JACC Cardiovasc Interv; 2014 Jan; 7(1):89-99. PubMed ID: 24139932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Step by step, the description of the "biodegradable" strategy for the treatment of coronary bifurcation lesions.
    Piraino D; Cimino G; Andolina G
    Int J Cardiol; 2016 Nov; 223():37-39. PubMed ID: 27529587
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.